These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 24940587)

  • 1. Reprocessing unsatisfactory ThinPrep papanicolaou tests using a modified SurePath preparation technique.
    Randolph ML; Wu HH; Crabtree WN
    Cancer Cytopathol; 2014 May; 122(5):343-8. PubMed ID: 24940587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unsatisfactory ThinPrep Pap Test: missed opportunity for disease detection?
    Bentz JS; Rowe LR; Gopez EV; Marshall CJ
    Am J Clin Pathol; 2002 Mar; 117(3):457-63. PubMed ID: 11888086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.
    Rinas AC; Mittman BW; Le LV; Hartmann K; Cayless J; Singh HK
    Acta Cytol; 2006; 50(1):55-62. PubMed ID: 16514841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of BD Surepath and ThinPrep Pap systems in the processing of mucus-rich specimens.
    Kenyon S; Sweeney BJ; Happel J; Marchilli GE; Weinstein B; Schneider D
    Cancer Cytopathol; 2010 Oct; 118(5):244-9. PubMed ID: 21113923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
    Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
    Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of p16INK4a and Ki-67 staining on cell blocks prepared from residual thin-layer cervicovaginal material.
    Akpolat I; Smith DA; Ramzy I; Chirala M; Mody DR
    Cancer; 2004 Jun; 102(3):142-9. PubMed ID: 15211472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprocessing unsatisfactory ThinPrep Papanicolaou test specimens increases sample adequacy and detection of significant cervicovaginal lesions.
    Islam S; West AM; Saboorian MH; Ashfaq R
    Cancer; 2004 Apr; 102(2):67-73. PubMed ID: 15098249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologic features of low-grade squamous intraepithelial lesion in thinprep papanicolaou test slides and conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
    Renshaw AA; Dubray-Benstein B; Haja J; Hughes JH;
    Arch Pathol Lab Med; 2005 Jan; 129(1):23-5. PubMed ID: 15628904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
    Bansal M; Zhao C
    J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the ThinPrep Pap test in clinical practice. A seven-month, 16,314-case experience in northern Vermont.
    Papillo JL; Zarka MA; St John TL
    Acta Cytol; 1998; 42(1):203-8. PubMed ID: 9479341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
    Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
    Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ThinPrep versus conventional Papanicolaou smear in the cytologic follow-up of women with equivocal cervical smears.
    Negri G; Menia E; Egarter-Vigl E; Vittadello F; Mian C
    Cancer; 2003 Dec; 99(6):342-5. PubMed ID: 14681941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An Institutional Experience.
    Plummer RM; Kelting S; Madan R; O'Neil M; Dennis K; Fan F
    J Am Soc Cytopathol; 2021; 10(3):255-260. PubMed ID: 33736951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid-based cytology and conventional cervical smears: a comparison study in an Asian screening population.
    Cheung AN; Szeto EF; Leung BS; Khoo US; Ng AW
    Cancer; 2003 Dec; 99(6):331-5. PubMed ID: 14681939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of CellSolutions BestPrep® automated thin-layer liquid-based cytology Papanicolaou slide preparation and BestCyte® cell sorter imaging system.
    Delga A; Goffin F; Kridelka F; Marée R; Lambert C; Delvenne P
    Acta Cytol; 2014; 58(5):469-77. PubMed ID: 25277345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system.
    Bolick DR; Hellman DJ
    Acta Cytol; 1998; 42(1):209-13. PubMed ID: 9479342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
    Duby JM; DiFurio MJ
    Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and false-positive rate of the cytologic diagnosis of follicular cervicitis: observations from the College of American Pathologists Pap Educational Program.
    Auger M; Khalbuss W; Nayar R; Zhao C; Wasserman P; Souers R; Thomas N; Moriarty AT
    Arch Pathol Lab Med; 2013 Jul; 137(7):907-11. PubMed ID: 23808462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reporting rates of high-grade squamous intraepithelial lesions and their human papillomavirus testing and histologic follow-up results: A comparison between ThinPrep and SurePath preparations.
    Sinclair WD; Gibbons-Fideler IS; Shen R; Li Z
    Diagn Cytopathol; 2021 Aug; 49(8):959-963. PubMed ID: 33991062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of atypical squamous cells of undetermined significance on ThinPrep papanicolaou smears.
    Eltabbakh GH; Lipman JN; Mount SL; Morgan A
    Gynecol Oncol; 2000 Oct; 79(1):44-9. PubMed ID: 11006029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.